Smilax Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 29-12-2024
- Paid Up Capital ₹ 1.11 Cr
as on 29-12-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 148.42 Cr
as on 29-12-2024
- Satisfied Charges ₹ 10.70 Cr
as on 29-12-2024
- Revenue -52.56%
(FY 2024)
- Profit -76.69%
(FY 2024)
- Ebitda -56.96%
(FY 2024)
- Net Worth 2.77%
(FY 2024)
- Total Assets 8.77%
(FY 2024)
About Smilax Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.11 Cr.
The company currently has active open charges totaling ₹148.42 Cr. The company has closed loans amounting to ₹10.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mukut Goyal, Vibhor Goyal, and Anand Sharma serve as directors at the Company.
- CIN/LLPIN
U24232RJ2005PTC020676
- Company No.
020676
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- LocationJaipur, Rajasthan
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Smilax Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vibhor Goyal  | Director | 15-Mar-2018 | Current |
| Mukut Goyal | Director | 29-Apr-2005 | Current |
| Anand Sharma | Director | 05-Feb-2020 | Current |
Financial Performance of Smilax Healthcare.
Smilax Healthcare Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 52.56% decrease. The company also saw a substantial fall in profitability, with a 76.69% decrease in profit. The company's net worth moved up by a moderate rise of 2.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Smilax Healthcare?
Unlock access to Smilax Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Biogenetic Drugs Private LimitedActive 20 years 11 monthsMukut Goyal and Vibhor Goyal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 27 Jun 2024 | ₹9.34 Cr | Open |
Hdfc Bank Limited Creation Date: 27 Mar 2023 | ₹3.20 M | Open |
State Bank Of India Creation Date: 19 May 2022 | ₹6.00 Cr | Open |
How Many Employees Work at Smilax Healthcare?
Unlock and access historical data on people associated with Smilax Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Smilax Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smilax Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
